Ayala Pharmaceuticals Revenu
Quel est le Revenu de Ayala Pharmaceuticals?
Le Revenu de Ayala Pharmaceuticals Inc. est $500.000k
Quelle est la définition de Revenu?
Le revenu est le revenu qu'une entreprise tire de ses activités commerciales normales, généralement de la vente de biens et de services aux clients.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenu des entreprises dans Health Care secteur sur NASDAQ par rapport à Ayala Pharmaceuticals
Que fait Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Entreprises avec revenu similaire à Ayala Pharmaceuticals
- Pharmadrug a Revenu de CAD$494.600k
- Soligenix Inc a Revenu de $494.623k
- XPhyto Therapeutics a Revenu de CAD$494.772k
- Ilika plc a Revenu de £496.103k
- Vivani Medical Inc a Revenu de $497.000k
- International Zeolite a Revenu de CAD$498.000k
- Ayala Pharmaceuticals a Revenu de $500.000k
- Cardax a Revenu de $500.707k
- Epigenomics AG a Revenu de €504.000k
- Genesys Industries a Revenu de $506.125k
- Genesys Industries a Revenu de $506.125k
- Genesys Industries a Revenu de $506.125k
- Comet Industries a Revenu de CAD$506.695k